EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Rapid Detection of SARS-CoV-2 RNA Using Reverse Transcription Recombinase Polymerase Amplification (RT-RPA) with Lateral Flow for N-Protein Gene and Variant-Specific Deletion–Insertion Mutation in S-Protein Gene

Jose L Malaga iD, Monica J Pajuelo iD, Michiko Okamoto iD, Emmanuel Kagning Tsinda iD, Kanako Otani iD, Pablo Tsukayama, Lucero Mascaro, Diego Cuicapuza iD, Masamichi Katsumi, Kazuhisa Kawamura, Hidekazu Nishimura, Akie Sakagami iD und 11 weitere

Viruses · 2023

DOI: 10.3390/v15061254 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Viruses, 2023. Verfasst von Jose L Malaga und 22 weiteren Autor:innen. Beteiligte Einrichtung: Department of Virology, Tohoku University Graduate School of Medicine, Sendai 980-8575, Japan. Hauptthemen laut MEDLINE: Reverse Transcription, COVID-19. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 55 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Japan Society for the Promotion of Science Fund, KAKENHI, Japan Agency for Medical Research and Development (AMED), National Fund for Scientific, Technological Development, and Innovation (FONDECYT).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Rapid molecular testing for severe acute respiratory coronavirus 2 (SARS-CoV-2) variants may contribute to the development of public health measures, particularly in resource-limited areas. Reverse transcription recombinase polymerase amplification using a lateral flow assay (RT-RPA-LF) allows rapid RNA detection without thermal cyclers. In this study, we developed two assays to detect SARS-CoV-2 nucleocapsid (N) gene and Omicron BA.1 spike (S) gene-specific deletion–insertion mutations (del211/ins214). Both tests had a detection limit of 10 copies/µL in vitro and the detection time was approximately 35 min from incubation to detection. The sensitivities of SARS-CoV-2 (N) RT-RPA-LF by viral load categories were 100% for clinical samples with high (>9015.7 copies/µL, cycle quantification (Cq): < 25) and moderate (385.5–9015.7 copies/µL, Cq: 25–29.9) viral load, 83.3% for low (16.5–385.5 copies/µL, Cq: 30–34.9), and 14.3% for very low (

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Reverse TranscriptionCOVID-19HumansRecombinasesRNA, ViralSARS-CoV-2Sensitivity and SpecificityMutagenesis, InsertionalNucleic Acid Amplification TechniquesNucleotidyltransferases

Stichwörter der Autor:innen

COVID-19SARS-CoV-2deletion–insertion mutationrecombinase polymerase amplification (RPA)variant of concern (VOC)

Substanzen

RecombinasesRNA, ViralNucleotidyltransferases

Autor:innen und Institutionen

  • Department of Virology, Tohoku University Graduate School of Medicine, Sendai 980-8575, Japan.
  • Laboratorio Microbiología Molecular, Laboratorios de Investigación y Desarrollo, Facultad de Ciencias y Filosofía, Universidad Peruana Cayetano Heredia, Lima 15102, Peru.
  • Center for Biomedical Innovation, Sinskey Lab, Massachusetts Institute of Technology, Cambridge, MA 02139, USA.
  • National Institute of Infectious Diseases, Tokyo 162-8640, Japan.
  • Laboratorio de Genómica Microbiana, Universidad Peruana Cayetano Heredia, Lima 15102, Peru.
  • Sendai City Institute of Health, Sendai 984-0002, Japan.

ORCID-Profile: Jose L Malaga, Monica J Pajuelo, Michiko Okamoto, Emmanuel Kagning Tsinda, Kanako Otani, Diego Cuicapuza, Akie Sakagami, Eiichi Kodama

Förderung

  • Japan Society for the Promotion of Science Fund, KAKENHI
  • Japan Agency for Medical Research and Development (AMED)
  • National Fund for Scientific, Technological Development, and Innovation (FONDECYT)
  • Ministry of Education, Culture, Sports, Science, and Technology Scholarship

Zitieren

APA

Malaga, J. L., Pajuelo, M. J., Okamoto, M., Tsinda, E. K., Otani, K., Tsukayama, P., Mascaro, L., Cuicapuza, D., Katsumi, M., Kawamura, K., Nishimura, H., Sakagami, A., Ueki, Y., Omiya, S., Okamoto, S., Nakayama, A., Fujimaki, S. I., Yu, C., Azam, S., …, & Saito, M. (2023). Rapid Detection of SARS-CoV-2 RNA Using Reverse Transcription Recombinase Polymerase Amplification (RT-RPA) with Lateral Flow for N-Protein Gene and Variant-Specific Deletion–Insertion Mutation in S-Protein Gene. Viruses. https://doi.org/10.3390/v15061254

Vancouver

Malaga JL, Pajuelo MJ, Okamoto M, Tsinda EK, Otani K, Tsukayama P, et al. Rapid Detection of SARS-CoV-2 RNA Using Reverse Transcription Recombinase Polymerase Amplification (RT-RPA) with Lateral Flow for N-Protein Gene and Variant-Specific Deletion–Insertion Mutation in S-Protein Gene. Viruses. 2023. doi:10.3390/v15061254

BibTeX
@article{Malaga2023,
  author = {Malaga, Jose L and Pajuelo, Monica J and Okamoto, Michiko and Tsinda, Emmanuel Kagning and Otani, Kanako and Tsukayama, Pablo and Mascaro, Lucero and Cuicapuza, Diego and Katsumi, Masamichi and Kawamura, Kazuhisa and Nishimura, Hidekazu and Sakagami, Akie and Ueki, Yo and Omiya, Suguru and Okamoto, Satoshi and Nakayama, Asami and Fujimaki, Shin-Ichi and Yu, Chuyao and Azam, Sikandar and Kodama, Eiichi and Dapat, Clyde and Oshitani, Hitoshi and Saito, Mayuko},
  title = {Rapid Detection of SARS-CoV-2 RNA Using Reverse Transcription Recombinase Polymerase Amplification (RT-RPA) with Lateral Flow for N-Protein Gene and Variant-Specific Deletion–Insertion Mutation in S-Protein Gene},
  journal = {Viruses},
  year = {2023},
  doi = {10.3390/v15061254}
}
Kostenlos starten →